| Nome |
# |
|
Antioxidant treatment of hindlimb-unloaded mouse counteracts fiber type transition but not atrophy of disused muscles, file dd9e0c63-a1ce-1e9c-e053-3a05fe0a45ef
|
239
|
|
Fluvastatin and atorvastatin affect calcium homeostasis of rat skeletal muscle fibers in vivo and in vitro by impairing the sarcoplasmic reticulum/mitochondria Ca2+-release system, file dd9e0c63-acca-1e9c-e053-3a05fe0a45ef
|
198
|
|
Pharmacovigilance database search discloses ClC-K channels as a novel target of the AT1 receptor blockers valsartan and olmesartan, file dd9e0c64-f069-1e9c-e053-3a05fe0a45ef
|
114
|
|
Growth hormone secretagogues hexarelin and JMV2894 protect skeletal muscle from mitochondrial damages in a rat model of cisplatin-induced cachexia, file dd9e0c64-a5b1-1e9c-e053-3a05fe0a45ef
|
89
|
|
Ryanodine channel complex stabilizer compound S48168/ARM210 as a disease modifier in dystrophin-deficient mdx mice: proof-of-concept study and independent validation of efficacy., file dd9e0c64-e1a0-1e9c-e053-3a05fe0a45ef
|
89
|
|
Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatin-induced cachexia, file dd9e0c64-0c65-1e9c-e053-3a05fe0a45ef
|
77
|
|
Effects of Nandrolone in the counteraction of skeletal muscle atrophy in a mouse model of muscle disuse: molecular biology and functional evaluation, file dd9e0c63-a471-1e9c-e053-3a05fe0a45ef
|
61
|
|
Statins and fenofibrate affect skeletal muscle chloride conductance in rats by different impairing ClC-1 channel regulation and expression, file dd9e0c63-af57-1e9c-e053-3a05fe0a45ef
|
61
|
|
Elucidating the Contribution of Skeletal Muscle Ion Channels to Amyotrophic Lateral Sclerosis in search of new therapeutic options, file dd9e0c65-8cb6-1e9c-e053-3a05fe0a45ef
|
53
|
|
Kv1.1 channelopathies: Pathophysiological mechanisms and therapeutic approaches, file dd9e0c67-a7f7-1e9c-e053-3a05fe0a45ef
|
51
|
|
Therapeutic approaches to genetic ion channelopathies and perspectives in drug discovery, file dd9e0c63-7852-1e9c-e053-3a05fe0a45ef
|
39
|
|
Cisplatin-Induced Skeletal Muscle Dysfunction: Mechanisms and Counteracting Therapeutic Strategies, file dd9e0c66-c059-1e9c-e053-3a05fe0a45ef
|
39
|
|
Statin-induced myotoxicity is exacerbated by aging: A biophysical and molecular biology study in rats treated with atorvastatin, file 532a9616-86bc-4c73-a539-5e57ac807860
|
38
|
|
Functional Study of Novel Bartter's Syndrome Mutations in ClC-Kb and Rescue by the Accessory Subunit Barttin Toward Personalized Medicine, file dd9e0c66-b614-1e9c-e053-3a05fe0a45ef
|
34
|
|
ATP Sensitive Potassium Channels in the Skeletal Muscle Function: Involvement of the KCNJ11(Kir6.2) Gene in the Determination of Mechanical Warner Bratzer Shear Force, file dd9e0c63-666d-1e9c-e053-3a05fe0a45ef
|
29
|
|
On the metabolically active form of metaglidasen: improved synthesis and investigation of its peculiar activity on peroxisome proliferator-activated receptors and skeletal muscles, file dd9e0c6c-8d86-1e9c-e053-3a05fe0a45ef
|
27
|
|
Statin-induced myotoxicity is exacerbated by aging: A biophysical and molecular biology study in rats treated with atorvastatin, file dd9e0c63-82b7-1e9c-e053-3a05fe0a45ef
|
13
|
|
Protein kinase C theta (PKCθ) modulates the ClC-1 chloride channel activity and skeletal muscle phenotype: a biophysical and gene expression study in mouse models lacking the PKCθ., file dd9e0c68-9890-1e9c-e053-3a05fe0a45ef
|
12
|
|
Kidney CLC-K chloride channels inhibitors: structure-based studies and efficacy in hypertension and associated CLC-K polymorphisms., file dd9e0c63-890f-1e9c-e053-3a05fe0a45ef
|
10
|
|
Taurine and skeletal muscle ion channels, file dd9e0c68-59d4-1e9c-e053-3a05fe0a45ef
|
9
|
|
In-vivo administration of CLC-K kidney chloride channels inhibitors increases water diuresis in rats: A new drug target for hypertension?, file dd9e0c68-d478-1e9c-e053-3a05fe0a45ef
|
7
|
|
Growth hormone secretagogues exert differential effects on skeletal muscle
calcium homeostasis in male rats depending on the peptidyl/non-peptidyl
structure, file dd9e0c63-0342-1e9c-e053-3a05fe0a45ef
|
6
|
|
Targeting kidney CLC-K channels: pharmacological profile in a human cell line versus Xenopus oocytes, file dd9e0c63-4693-1e9c-e053-3a05fe0a45ef
|
6
|
|
Calcium homeostasis is altered in skeletal muscle of spontaneously hypertensive rats cytofluorimetric and gene expression analysis, file dd9e0c64-60af-1e9c-e053-3a05fe0a45ef
|
6
|
|
Sarcoplasmic Reticulum Ca2+ Buffer Proteins: A Focus on the Yet-To-Be-Explored Role of Sarcalumenin in Skeletal Muscle Health and Disease, file 5acb27a2-f6d4-48cf-b906-17dc0b94a59b
|
4
|
|
null, file dd9e0c63-1f1f-1e9c-e053-3a05fe0a45ef
|
4
|
|
Paracrine Effects of IGF-1 Overexpression on the Functional Decline Due to Skeletal Muscle Disuse: Molecular and Functional Evaluation in Hindlimb Unloaded MLC/mIgf-1 Transgenic Mice, file dd9e0c64-5c8a-1e9c-e053-3a05fe0a45ef
|
4
|
|
null, file dd9e0c64-ad10-1e9c-e053-3a05fe0a45ef
|
4
|
|
Protein kinase C theta (PKCθ) modulates the ClC-1 chloride channel activity and
skeletal muscle phenotype: a biophysical and gene expression study in mouse
models lacking the PKCθ, file dd9e0c68-c45b-1e9c-e053-3a05fe0a45ef
|
4
|
|
Alteration of excitation-contraction coupling mechanism in extensor digitorum longus muscle fibres of dystrophic mdx mouse and potential efficacy of taurine, file dd9e0c63-a200-1e9c-e053-3a05fe0a45ef
|
3
|
|
Sodium-glucose cotransporter-2 inhibitors: A potential novel treatment for Lafora disease?, file 1981ecd4-5058-4943-a0d3-e4e97e7a5ece
|
2
|
|
Brugada Syndrome: More than a Monogenic Channelopathy, file 5fef801b-9202-46a4-889e-679d5c8527eb
|
2
|
|
Small Molecules Targeting Kidney ClC-K Chloride Channels: Applications in Rare Tubulopathies and Common Cardiovascular Diseases, file 6eaa0c2e-b1f6-4a8d-be8f-cdfa31fb6101
|
2
|
|
Branched-Chain Amino Acids and Di-Alanine Supplementation in Aged Mice: A Translational Study on Sarcopenia, file bfb79dd0-b736-4b4f-8a0c-9877b2e78901
|
2
|
|
Potential benefits of taurine in the prevention of skeletal muscle impairment induced by disuse in the hindlimb-unloaded rat, file dd9e0c62-8909-1e9c-e053-3a05fe0a45ef
|
2
|
|
I-J loop involvement in the pharmacological profile of CLC-K channels expressed
in Xenopus oocytes, file dd9e0c63-8b60-1e9c-e053-3a05fe0a45ef
|
2
|
|
Structural requisites of 2-(p-chlorophenoxy)propionic acid analogues for activity on native rat skeletal muscle chloride conductance and on heterologously expressed CLC-1, file dd9e0c63-a198-1e9c-e053-3a05fe0a45ef
|
2
|
|
Disuse of rat muscle in vivo reduces protein kinase C activity controlling the sarcolemma chloride conductance, file dd9e0c63-a2d0-1e9c-e053-3a05fe0a45ef
|
2
|
|
JMV2894, a novel growth hormone secretagogue, accelerates body mass recovery in an experimental model of cachexia, file dd9e0c64-0b60-1e9c-e053-3a05fe0a45ef
|
2
|
|
null, file dd9e0c64-60b0-1e9c-e053-3a05fe0a45ef
|
2
|
|
null, file dd9e0c64-d31a-1e9c-e053-3a05fe0a45ef
|
2
|
|
Taurine and skeletal muscle ion channels, file dd9e0c65-fc23-1e9c-e053-3a05fe0a45ef
|
2
|
|
On the metabolically active form of metaglidasen: improved synthesis and investigation of its peculiar activity on peroxisome proliferator-activated receptors and skeletal muscles, file dd9e0c66-6838-1e9c-e053-3a05fe0a45ef
|
2
|
|
Gain-of-Function STIM1 L96V Mutation Causes Myogenesis Alteration in Muscle Cells From a Patient Affected by Tubular Aggregate Myopathy, file dd9e0c6a-fceb-1e9c-e053-3a05fe0a45ef
|
2
|
|
A novel kcna2 variant in a patient with non-progressive congenital ataxia and epilepsy: Functional characterization and sensitivity to 4-aminopyridine, file dd9e0c6b-51d8-1e9c-e053-3a05fe0a45ef
|
2
|
|
Niflumic acid inhibits chloride conductance of rat skeletal muscle by directly inhibiting the CLC-1 channel and by increasing intracellular calcium, file dd9e0c62-6821-1e9c-e053-3a05fe0a45ef
|
1
|
|
null, file dd9e0c63-a428-1e9c-e053-3a05fe0a45ef
|
1
|
|
Phosphorylation and IGF-1-mediated dephosphorylation pathways control the
activity and the pharmacological properties of skeletal muscle chloride channels, file dd9e0c63-a701-1e9c-e053-3a05fe0a45ef
|
1
|
|
Growth hormone secretagogues modulate the electrical an contractile properties of rat skeletal muscle through a ghrelin-specific receptor, file dd9e0c63-a7eb-1e9c-e053-3a05fe0a45ef
|
1
|
|
Pre-clinical trials in Duchenne dystrophy: what animal models can tell us about potential drug effectiveness, file dd9e0c63-a7f1-1e9c-e053-3a05fe0a45ef
|
1
|
|
Effect of HMG-CoA reductase inhibitors on excitation-contraction coupling of rat skeletal muscle, file dd9e0c63-a93b-1e9c-e053-3a05fe0a45ef
|
1
|
|
The alteration of calcium homeostasis in adult dystrophic mdx muscle fibers is worsened by a chronic exercise in vivo, file dd9e0c63-aa2a-1e9c-e053-3a05fe0a45ef
|
1
|
|
Identification of sites responsible for the potentiating effect of niflumic acid on ClC-Ka kidney chloride channels, file dd9e0c63-aa7d-1e9c-e053-3a05fe0a45ef
|
1
|
|
Enhanced dystrophic progression in mdx mice by exercise and beneficial effects of taurine and insulin-like growth factor-1, file dd9e0c63-acd7-1e9c-e053-3a05fe0a45ef
|
1
|
|
Pharmacological characterization of chloride channels belonging to the ClC family by the use of chiral clofibric acid derivatives, file dd9e0c63-ae80-1e9c-e053-3a05fe0a45ef
|
1
|
|
null, file dd9e0c64-a8b4-1e9c-e053-3a05fe0a45ef
|
1
|
|
Paving the way for Bartter syndrome type 3 drug discovery: a hope from basic research, file dd9e0c64-e109-1e9c-e053-3a05fe0a45ef
|
1
|
|
Ion channels in drug discovery and safety pharmacology, file dd9e0c65-8457-1e9c-e053-3a05fe0a45ef
|
1
|
|
Gentamicin treatment in exercised mdx mice: Identification of dystrophin-sensitive pathways and evaluation of efficacy in work-loaded dystrophic muscle, file dd9e0c66-5aa4-1e9c-e053-3a05fe0a45ef
|
1
|
|
Increased sarcolemma chloride conductance as one of the mechanisms of action of carbonic anhydrase inhibitors in muscle excitability disorders, file dd9e0c6b-8198-1e9c-e053-3a05fe0a45ef
|
1
|
|
Multiple pathological events in exercised dystrophic mdx mice are targeted by pentoxifylline: Outcome of a large array of in vivo and ex vivo tests, file dd9e0c6b-a55d-1e9c-e053-3a05fe0a45ef
|
1
|
| Totale |
1.376 |